Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Clinical trial NCT05287165 · UNKNOWN

Trial details

NCT number: NCT05287165
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Digestive System Neoplasms Pancreatic Cancer Resectable Colorectal (Colon or Rectal) Cancer

Start date: 2022-03-10
Primary completion: 2024-04-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.